下载文档原格式
XXXX年1月个人思想汇报范文尊敬的党组织：以下是我这两个月的思想汇报，请提出批评指正意见。
现在是大三最后的阶段了，身边的每一个同学都非常努力，一心想读研深造的同学都在抓紧最后的机会提升加权，撰写论文，为自己申请夏令营增加筹码;想出国完成学业的同学在积极准备各种外语考试等等;希望能直接工作的同学同样在紧张的抓住最后的几个月来为自己充充电为了给自己的大学生涯带来一个美好的结果，所有人都卯足了劲，做好大概一场的准备。
大家都如此努力，其实仔细想想也不过分，现在的社会竞争如此激烈，对高素质、高科技人才的需求越来越多，但由于近年来高校扩招持续进行，越来越多的高校毕业生每年涌入就业市场，大学的就业情况仍然不容乐观，研究生也不一定意味着高枕无忧，所以要努力牺牲自己的能力，以便在时代的竞争潮流中谋寻到自己的立足之地。
但要真正提升自己的能力，不能单靠一两个月的临时抱佛脚，包装一下，要在日常的学习生活就慢慢沉淀积累自己的能力，否则就算了蒙蔽别人一时，也不能忽悠太久，这也只是华而不实而已，终究不能在社会竞争中取得胜利，最终将被社会所遗忘。
回想自己前三年在华科的日子，说长不长，说短也不短，学会了很多东西，也还有很多东西没有学会，不管怎么样，都发觉自己越来越爱上了这座森林式大学了，春天的玉兰香，夏日的荷花笑，秋风里的梧桐叶，冬风下的喻咖上，一切的一切承载了多少华科褶子的青葱岁月，我们在这片土地上学习、成长、结交知己好友，学习浓郁的华科锻造了华科人坚韧的品质激情学好问的心性。
这些都是难能可贵的品质，是用多少金钱都换不回来的，值得花个人用一辈子来践行。
华科培养了我们，而我们也是华科最好的明信片，努力做一个完善人格的社会人，做一个对社会有贡献的人，才能不枉费母校、社会和家人对我们多年来的培养。
同时，从大方面来说，党和国家花了无数心血也在教育上，希望能"科技新国，人才强国' ，让更多的人民进入小康生活，完成中华民族之伟大复兴，让我们国家更好地屹立于世界民族之林。
内部承包协议甲方：乙方：**********工程项目经 ******* 投资运作中标，并经有限公司（以下称甲方）同意，成立***项目监理部（以下称乙方），由 **** 身份证号：**************** 全权负责。
为健全发展，便于工作和管理，有规可循，双方经协商一致并达成如下协议，以资共同信守。
一、合作方式：1、项目名称： *******项目监理部；范围：**********项目;内容：甲方与业主签订的合同内容。
双方应坦诚合作，本着合作双方双赢的原则，始终应坚持信誉第一，经济利益第二，维护公司形象，在争创经济效益的同时，争创优良的社会效益。
2、协议有效期间乙方可在甲方资质证书规定的范围内开展项目管理，项目监理部实行内部经济独立核算。
二、双方职责：（一）甲方职责：1、甲方负责提供公司各有效证件和相关项目管理项目手续的办理,并对乙方派出的项目管理人员进行任命。
2、甲方负责与业主签订工程项目管理承包服务合同。
按本协议第三条款约定及时向乙方拨付款项,不得将本项目项目管理费挪作它用，否则承担因此造成项目停工损失及赔偿责任。
配合乙方收集项目管理资料及归档。
3、甲方负责合理指挥、指导乙方工作，对乙方工作监督，有提供技术指导服务的义务。
公司对乙方检查所产生的差旅费由乙方负责。
甲方有权监督项目乙方的项目管理业务、技术，使之严格执行国家项目管理规范的有关规定。
并定期对乙方履行项目管理职责的成效情况和业主满意度对业主进行回访。
4、甲方负责按要求委派项目总监理工程师（不须常住工地）或甲方现场管理代表（常住工地）。
总监理工程师参与重要的检查验收、项目管理资料签字、及时出席需要总监理工程师参加的会议。
总监理工程师出席项目各种活动的差旅费（实报实销），并按日补助300元，总项目管理工程师和总监理工程师的兼职工资每月1500元由乙方承担（注：总监理工程师的兼职工资从工程正式开工算起至竣工验收），如需总监长驻工地上班，费用双方另行商定（工资不能高于市场平均价），并由乙方承担。
安全管理领导力打印稿XXXX(1)安全管理领导力打印稿XXXX随着全球产业经济的快速发展，安全管理问题日益凸显出其重要性，安全管理已成为企业发展的重要组成部分。
在安全管理中，领导力起着重要的作用。
本文将围绕“安全管理领导力”这一主题，从领导力的定义、领导力在安全管理中的作用、如何提高安全管理领导力几方面展开论述。
第一部分：领导力的定义领导力是指领导者在组织中产生影响的能力。
与管理力不同的是，领导力更关注于提高员工工作的积极性、创造性和创新性。
领导力不是与生俱来的能力，它需要长期的培养和锤炼。
领导力不仅体现在能够带领团队达成目标上，更关注于影响力、信任度、目标感和行动力等个人特质的塑造。
第二部分：领导力在安全管理中的作用领导力在安全管理中是不可或缺的。
有效的领导可以推动安全管理制度的执行，提高员工的安全意识，鼓励员工开展安全检查并及时解决安全隐患。
在企业出现安全事故时，领导应带领团队全面分析事故原因并制定有效措施，共同防范类似事件再次发生。
第三部分：如何提高安全管理领导力1. 制定并执行完善的安全管理制度。
领导必须全面了解企业安全管理的具体情况，针对不同部门的风险制定对应的安全管理制度，并对制度执行情况进行监管和考核。
2. 团队建设和培训。
有团队合作和同理心的领导更容易通过与员工间的互动和交流，传递安全意识和核心价值，更好地塑造员工安全文化。
3. 实施激励机制。
领导可以建立奖惩激励机制，激励员工参与企业安全管理并发挥创造力。
同时，领导应根据员工实际情况，确定奖惩的力度和方式。
4. 持续改进。
领导应始终保持关注企业安全管理实际情况，并利用反馈机制及时调整管理方式并多次三次进行结构体系的完全优化。
总之，领导力在安全管理中是重要的资源，领导具有完善的领导力可以更好地执行安全绩效计划，提高企业安全管理水平，增强企业的核心竞争力。
因此，企业应大力挖掘和培养领导人的领导力，共同打造坚如磐石的安全管理体系。
Sample Letter to Document Disability From Primary Care PhysicianTo Vocational RehabilitationDateTO: NAME OF VR COUNSELOROffice of Rehabilitation ServicesADDRESSCITY, STATEFROM: DOCTOR’s NAME (its better if this is on the physician’s letterhead)RE: John (XXXXXX) XXXXXXX, Age 18, DOB XX/XX/1986Phone: XXX-XXX-XXXXGraduate of XXXXXX High School as of June 9, 2004Dear NAME OF VR COUNSELOR,The purpose of this letter is to document significant chronic health conditions that impair activities of daily living for XXXXXXX – XXXXXX. I have been his primary care physician for18 years.XXXXXX’s health issues and their effect on school and potential employment do meet the definition of disability by Utah’s Vocational Rehabilitation criteria [Title 53A Chapter 24, 102(3)] and ADA and Section 504 requirements (see fact sheet on last page).SIGNIFICANT HEALTH IMPAIRMENTS• Endocrine System - TYPE ONE DIABETES• Digestive System - ULCERATIVE COLITIS• Immune System - ANKYLOSING SPONDYLITISCONFIDENTIALITY SAFEGUARDS - In compliance with HIPAA confidentiality mandates permission for this personal health information has been obtained by the patient, and as such this letter should be treated as highly confidential records and not shared without the patient’s permission.What follows is an overview of the health issues that XXXXXX lives with. Enclosed are relevant reports and findings of recent and past health related medical testing.TRAINING FOR EMPLOYMENT & IMPORTANT OF HEALTH CARE BENEFITSIt is important to consider what XXXXXX could do to meet his potential, live independently, and remain as healthy as possible. XXXXXX is a very bright young man who has displayed numerous talents in music, art, writing, literature, and science.Given his educational performance, intellectual abilities and aspirations, he certainly has the potential to do well in competitive employment through post-secondary college courses – if supported. It will be essential that career development be aimed at stable; well-paying jobs that offer comprehensive benefits to assure maintain health status and financial independence.In sum, I believe that offering XXXXXX financial and technology support through the Office of Rehabilitative Services would ensure not only employability but also would support all important aspects of independent living and optimal quality of life. Please contact me if you require further information.Sincerely,XXXXXXXXX, M.D.Etc.XXXXXX XXXXXX Chronic Health Issues1. TYPE ONE DIABETES, ICD-9 CODE: 250.01, Diagnosed: 1998; age 12 yearsHealth Impact to XXXXXX – He requires daily insulin, strict dietary management, and daily/hourlymonitoring and management of blood sugar levels. He has been hospitalized several times, either forsevere hypoglycemia or ketoacidosis.2. ULCERATIVE COLITIS, ICD-9 CODE: 556.9, Diagnosed: Diagnosed 2000; age 14 yearsXXXXXX required surgery for this. He had a colectomy.Health Impact to XXXXXX – Although he technically no longer has ulcerative colitis due to the absence of a colon, he continues to suffer from acute episodes of pouchitis. Symptoms, including steadily increasingstool frequency that may be accompanied by incontinence, bleeding, fever and/or feeling of urgency. Most cases can be treated with a short course of antibiotics. Additionally, absence of a colon causes problemswith nutritional absorption and is associated with XXXXXX’s below-average weight.3. ANKYLOSING SPONDYLITIS, ICD-9 CODE: 720.0, Diagnosed: 2000; age 14 yearsHealth Impact to XXXXXX – his degenerative spinal arthritis that causes episodes of severe pain andlimitations on his physical capabilities, requiring medication and a physical therapy regime formanagement.ACCOMODATIONS REQUIRED – SCHOOL /EMPLOYMENT TRAINING/PREPARATIONIn order to maximize XXXXXX’s performance level that will not jeopardize health status, some accommodations and modifications are required:1. DAILY MONITORING- XXXXXX’s diabetes management requires that he be able to take frequent breaks whenthe need arises to a) treat low blood sugars, b) use the restroom, c) test his glucose levels, and d) administer insulin. Although XXXXXX’s diabetes management has been relatively stable, the presence of additionalautoimmune diseases puts his future diabetes management and long-term health at risk.2. WATER INTAKE & BATHROOM BREAKS - XXXXXX’s lack of a colon causes him to use the restroom frequently,and he must drink a large amount of water throughout the day to prevent dehydration.3. LIMIT PHYSICAL EXERTION - His ankylosing spondylitis causes him days with severe back pain, makingrigorous activity very painful. Tasks requiring heavy lifting or having to sit or stand for a prolonged period of time without breaks exacerbate his condition and are harmful to his spine. Class schedules and location of classrooms, time needed to change travel to next class need to be evaluated. There may be a need foradditional accommodations in the future, such as mobility assistance, elevator use, use of laptop or cell phone to alleviate unnecessary physical travel.4. ATTENDANCE - Episodes of severe hypoglycemia or ketoacidosis, pouchitis infections, and severe spinal paincan result in XXXXXX’s need for additional sick days to treat the accompanying fever, diarrhea, and abdominal pain. Teachers will need to allow for increased time to make up schoolwork or other forms of instruction if absenteeism is due to noted health issues.5. ACCOMODATIONS - XXXXXX has had a 504 plan in place at school (K-12) to ensure these accommodationshave been allowed. The individualized employment plan / individual written rehabilitation plan, that will be developed between VR and XXXXXX will need to specify needed accommodations. While in college, XXXXXX will need to coordinate accommodations (health, learning and testing) for maximized performance with the Disability Resource Centers on campus.。
Guidance for Industry 行业指南Process Validation: General Principles and Practices工艺验证：一般原则与规范U.S. Department of Health and Human ServicesFood and Drug AdministrationCenter for Drug Evaluation and Research (CDER)Center for Biologics Evaluation and Research (CBER)Center for Veterinary Medicine (CVM)January 2011Current Good Manufacturing Practices (CGMP)Revision 1美国卫生与人类服务部食品药品管理局药物评价和研究中心（CDER）生物制品评价和研究中心（CBER）兽药中心（CVM）2011年1月现行药品质量生产管理规范（CGMP）修订版1包含不具约束力的建议中文译稿：北京大学药物信息与工程研究中心info@ Guidance for Industry 行业指南Process Validation: General Principles and Practices工艺验证：一般原则与规范Additional copies are available from:Office of CommunicationsDivision of Drug Information, WO51, Room 220110903 New Hampshire Ave.Silver Spring, MD 20993Phone: 301-796-3400; Fax: 301-847-8714druginfo@/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htmand/orOffice of Communication, Outreach and Development, HFM-40Center for Biologics Evaluation and ResearchFood and Drug Administration1401 Rockville Pike, Rockville, MD 20852-1448(Tel) 800-835-4709 or 301-827-1800/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm and/orCommunications Staff, HFV-12Center for Veterinary MedicineFood and Drug Administration7519 Standish Place,Rockville, MD 20855(Tel) 240-276-9300/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/default.htm包含不具约束力的建议中文译稿：北京大学药物信息与工程研究中心info@另外的副本可从以下部门得到：马里兰州银泉市新罕布什尔大道10193号2201室药品信息处，对外信息办公室，邮政编码：20993电话：301-796-3400; 传真：301-847-8714druginfo@/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm和/或马里兰州洛克维尔市洛克维尔大道1401号HFM-40 FDA生物制品评价和研究中心对外信息、外联与发展办公室邮政编码：20852-1448电话：800-835-4709 或301-827-1800/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm和/或马里兰州洛克维尔市Standish Place 7519号食品药品管理局兽药中心HFV-12通讯处，邮政编码：20885电话：240-276-9300/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/default.htmU.S. Department of Health and Human ServicesFood and Drug AdministrationCenter for Drug Evaluation and Research (CDER)Center for Biologics Evaluation and Research (CBER)Center for Veterinary Medicine (CVM)January 2011Current Good Manufacturing Practices (CGMP)Revision 1美国卫生与人类服务部食品药品管理局药物评估和研究中心（CDER）生物制品评估和研究中心（CBER）兽药中心（CVM）2011年1月现行药品质量生产管理规范（CGMP）修订版1包含不具约束力的建议中文译稿：北京大学药物信息与工程研究中心info@Table of Contents目录I. INTRODUCTION (1)一. 简介 (1)II. BACKGROUND (3)二. 背景 (3)A. Process Validation and Drug Quality (4)A. 工艺验证与药品质量 (4)B. Approach to Process Validation (5)B. 工艺验证方法 (5)III. STATUTORY AND REGULATORY REQUIREMENTS FOR PROCESS VALIDATION (7)三. 对工艺验证的法规和监管要求 (7)IV. RECOMMENDATIONS (9)四. 建议 (9)A. General Considerations for Process Validation (9)A. 对工艺验证的总体考虑 (9)B. Stage 1 - Process Design (10)B. 第一阶段- 工艺设计 (10)1. Building and Capturing Process Knowledge and Understanding (11)1. 建立和捕获工艺知识与理解 (11)2. Establishing a Strategy for Process Control (12)2. 建立工艺控制策略 (12)C. Stage 2 - Process Qualification (14)C. 第二阶段- 工艺确认 (14)1. Design of a Facility and Qualification of Utilities and Equipment (14)1. 厂房设施设计以及公用设施与设备确认 (14)2. Process Performance Qualification (16)2. 工艺性能确认 (16)3. PPQ Protocol (17)3. 工艺性能确认方案 (17)4. PPQ Protocol Execution and Report (19)4. 工艺性能确认执行与报告 (19)D. Stage 3 - Continued Process Verification (20)D. 第三阶段- 持续工艺验证 (20)V. CONCURRENT RELEASE OF PPQ BATCHES (22)五. 工艺性能确认批次的同时放行 (22)VI. DOCUMENTATION (24)六. 文件记录 (24)VII. ANALYTICAL METHODOLOGY (24)七. 分析方法 (24)GLOSSARY (26)术语表 (26)REFERENCES (28)参考资料 (28)包含不具约束力的建议中文译稿：北京大学药物信息与工程研究中心info@1Guidance for Industry1行业指南1Process Validation: General Principles and Practices工艺验证：一般原则与实施This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You canuse an alternative approach if the approach satisfies the requirements of the applicable statutes andregulations. If you want to discuss an alternative approach, contact the FDA staff responsible forimplementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate numberlisted on the title page of this guidance.本指南体现了食品药品管理局（FDA）关于这一主题的最新见解。
